Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R
2014 · BMC Cancer · 118 citations
https://doi.org/10.1186/1471-2407-14-134
W
Wendong Bai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
868
Citations
15
h-index
16
i10-index
Wendong Bai is an academic researcher. The author has contributed to research in topics: Cancer-related molecular mechanisms research & MicroRNA in disease regulation & RNA Research and Splicing. The author has an h-index of 15, co-authored 25 publications.
ORCID: 0000-0003-1873-7900Papers by this author
worksMiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN
2014 · BMB Reports · 88 citations
https://doi.org/10.5483/bmbrep.2014.47.5.165
Knockdown of lncRNA-ATB suppresses autocrine secretion of TGF-β2 by targeting ZNF217 via miR-200c in keloid fibroblasts
2016 · Scientific Reports · 70 citations
https://doi.org/10.1038/srep24728
LINC00589-dominated ceRNA networks regulate multiple chemoresistance and cancer stem cell-like properties in HER2+ breast cancer
2022 · npj Breast Cancer · 18 citations
https://doi.org/10.1038/s41523-022-00484-0
NBPF7 promotes the proliferation of α-catenin-knockdown HaCaT cells via functional interaction with the NF-κB pathway
2017 · Oncotarget · 5 citations
https://doi.org/10.18632/oncotarget.19480
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat